medical device investing Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform
medical device investing Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
medical device investing Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments
medical device investing Accuray to Report Fourth Quarter Fiscal 2026 Financial Results on August 19, 2026
medical device investing Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
medical device investing Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026
medical device investing Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
medical device investing Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
medical device investing Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026
medical device investing Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth
Apex Extends Trinity Zone 200 m with 3.55% REO over 116.0 m and 2.35% over 171.5 m in Western Step-out Drilling at Rift
Goldera Expands High-Grade E1 Gold Discovery with Two New Parallel Structures Ahead of Planned Q4 Drilling at Egan Gold Project
Oreterra CEO Letter to Shareholders Provides Forward Guidance on Trek South Drill Results in Advance of Assays
